Organon & Co. (OGN)
13.76
+0.02
(+0.15%)
USD |
NYSE |
Oct 15, 16:00
13.76
0.00 (0.00%)
Pre-Market: 20:00
Organon SG&A Expense (TTM) : 1.706B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.706B |
| March 31, 2026 | 1.725B |
| December 31, 2025 | 1.721B |
| September 30, 2025 | 1.758B |
| June 30, 2025 | 1.765B |
| March 31, 2025 | 1.749B |
| December 31, 2024 | 1.76B |
| September 30, 2024 | 1.759B |
| June 30, 2024 | 1.875B |
| March 31, 2024 | 1.889B |
| December 31, 2023 | 1.893B |
| September 30, 2023 | 1.894B |
| June 30, 2023 | 1.796B |
| Date | Value |
|---|---|
| March 31, 2023 | 1.768B |
| December 31, 2022 | 1.704B |
| September 30, 2022 | 1.715B |
| June 30, 2022 | 1.663B |
| March 31, 2022 | 1.656B |
| December 31, 2021 | 1.667B |
| September 30, 2021 | 1.62B |
| June 30, 2021 | 1.553B |
| March 31, 2021 | 1.421B |
| December 31, 2020 | 1.356B |
| September 30, 2020 | 922.00M |
| June 30, 2020 | 601.00M |
| March 31, 2020 | 317.00M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Merck & Co., Inc. | 11.14B |
| Viatris, Inc. | 3.981B |
| Pfizer Inc. | 13.72B |
| Pacira Biosciences, Inc. | 338.66M |
| Bristol Myers Squibb Co. | 7.413B |